维普中文期刊产品整合服务
79篇 您的检索式:作者名="Rusthoven J"
    题名 作者 年代 出处 被引量
1Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural masothelioma 显示文摘Vogelzang NJ Rusthoven J J Symanowski J 2003J Clin Oncol2003,21,14:1
2Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin along in patients with malignant pleural mesothelioma 显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
3PhaseⅢstudy of pemetrexed in combination with cisplatin versus cisplatin alone in patients with magligant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 0,,:1
4Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘VOGELZANG NJ RUSTHOVEN J 2003J Clin Oncol2003,21,14:1
5Phase Ⅲ study of pemetrexd in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘 Rusthoven J Symanowski J 2003J Clin Oncol2003,21,14:1
6Multitargeted antifolate LY231514 as frist-line chemotherapy for patients with advanced non-small cell lung cancer:a phase Ⅱ study显示文摘RUSTHOVEN J EISENHAUER E BUTTS C 1999J Clin Oncol1999,17,4:1
7Phase Ⅲ study of Pemetrexed in combination with Cisplatin versus Cisplatin alone in patients with malignant pleural mesothelioma 显示文摘Vogelzang N J Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
8Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in pa- tients with malignant pleural mesothelioma 显示文摘Vogelzang N J Rusthoven JJ Symanowski J 2003Clin Oncol2003,21,14:1
9Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignantpleural mesothelioma显示文摘Vogelzang N J Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,:1
10Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,:1
11Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘VOGELZANG N J RUSTHOVEN J J SYMANOWSKI J 2003J Clin Oncol2003,21,14:1
12Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
13Phase Ⅲ study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma 显示文摘Vogelzang N J Rusthoven JJ Symanowski J 2003Clin Oncol2003,21,14:1
14Phasestudy of pemetrexed in combination with cisplatin versuscisplatin alone in patients with malignant pleural mesothe-lioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
15Phase Ⅲ study of peme trexed incombination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
16Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven JJ Symanowski J 2003J Clin Oncol2003,21,14:1
17Phase Ⅲ study of pemetrexedin emnhination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma显示文摘Vogelzang NJ Rusthoven J 2003J Clin Oncol2003,21,14:1
18Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer显示文摘HASSELLE M D HARAF D J RUSTHOVEN K E 0,,02:1
19Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cispla- tin Alone in Patients With Malignant Pleural Mesothelioma 显示文摘Vogelzang N J Rusthoven J J Symanowski J 2003Journal of Clinical Oneology2003,21,14:1
20Malignant pleural mesothelioma:update,current management,and newer therapeutic strategies显示文摘Pistolesi M Rusthoven J 2004Chest2004,126,:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费